Dispose of the syringe and needle in a sharps container
Results showed dose-dependent weight loss: the 0.25mg dose produced 4.5% additional weight loss beyond diet and placebo, the 0.5mg dose achieved 9.2% weight loss, and the 1.0mg dose resulted in 10.6% weight lossrepresenting approximately twice the efficacy of other approved obesity drugs available at that time
In June 2001, NeuroSearch decided to continue developing NS-2330 in-house after securing sufficient funding through a capital increase
Medications like semaglutide offer a powerful way to manage appetite and improve metabolic health, and for many, they are a safe and effective tool when used under medical supervision
Approved by the FDA in 2014 for type 2 diabetes and expanded in 2023 for chronic weight management, dulaglutide is administered as a once-weekly injection
Youll receive unwavering support from a team that carefully guides and tracks your progress every step of the way